Additionally, survivors may have underlying cancer predisposition syndromes, resulting in secondary leukemia; specifically, survivors with an initial diagnosis of osteosarcoma followed by subsequent leukemia may be associated with an underlying p53 mutation. Here, TP53 is linked to cancer.